Gabapentin and Pregabalin Cognitive Impairment Investigation
Case Overview
The investigation centers on whether the manufacturers of gabapentin (Neurontin) and pregabalin (Lyrica) adequately warned patients and healthcare providers regarding a possible connection between prolonged use of these medications and the development of dementia or cognitive impairment.
The allegations suggest that the drug makers might have been aware of potential cognitive risks associated with long-term use, that reports of memory issues were not sufficiently investigated, and that adequate warnings were not provided to patients and doctors. The claims involve individuals prescribed these drugs for an extended period who were subsequently diagnosed with early-onset dementia or cognitive impairment.
Attorneys are actively investigating these potential claims, and individuals who meet specific criteria—such as being prescribed the medication six or more times since 2000 for a condition other than seizures, and being diagnosed with early-onset dementia or cognitive impairment before age 65—may qualify to pursue compensation for damages like lost income and medical expenses. Interested parties are advised to complete a form to check their eligibility.
Who May Qualify
Individuals prescribed gabapentin (Neurontin) or pregabalin (Lyrica) six or more times since 2000, prescribed for a condition other than seizures, epilepsy, nerve pain, neuropathy, or shingles-related nerve pain, and diagnosed with early-onset dementia or cognitive impairment before age 65.
Frequently Asked Questions
What are the specific medications involved in this lawsuit investigation?
The investigation concerns gabapentin, sold under the brand name Neurontin, and pregabalin, which is sold under the brand name Lyrica. Both medications are classified as gabapentinoids.
What conditions might qualify someone for this investigation?
You may qualify if you were prescribed these medications for an extended time and were later diagnosed with early-onset dementia or cognitive impairment. Specific criteria include being prescribed the drug six or more times since 2000 for a non-seizure related condition.
Related Cases
Social Media Addiction Lawsuit
Ram 2500 Stability Control Recall